Annual Operating Expenses
$44.14 M
+$14.46 M+48.70%
December 31, 2024
Summary
- As of March 10, 2025, VYNE annual total operating expenses is $44.14 million, with the most recent change of +$14.46 million (+48.70%) on December 31, 2024.
- During the last 3 years, VYNE annual operating expenses has risen by +$4.30 million (+10.78%).
- VYNE annual operating expenses is now -66.83% below its all-time high of $133.08 million, reached on December 31, 2020.
Performance
VYNE Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$12.85 M
-$358.00 K-2.71%
December 1, 2024
Summary
- As of March 10, 2025, VYNE quarterly total operating expenses is $12.85 million, with the most recent change of -$358.00 thousand (-2.71%) on December 1, 2024.
- Over the past year, VYNE quarterly operating expenses has stayed the same.
- VYNE quarterly operating expenses is now -68.93% below its all-time high of $41.37 million, reached on March 31, 2020.
Performance
VYNE Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
VYNE Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.7% | 0.0% |
| 3 y3 years | +10.8% | 0.0% |
| 5 y5 years | -42.1% | 0.0% |
VYNE Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.7% | -2.7% | +115.2% |
| 5 y | 5-year | -66.8% | +48.7% | -68.9% | +115.2% |
| alltime | all time | -66.8% | +857.9% | -68.9% | +139.1% |
VYNE Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $44.14 M(+48.7%) | - |
| Dec 2024 | - | $12.85 M(-2.7%) |
| Sep 2024 | - | $13.21 M(+24.7%) |
| Jun 2024 | - | $10.59 M(+41.7%) |
| Mar 2024 | - | $7.48 M(+8.3%) |
| Dec 2023 | $29.68 M(-14.6%) | $6.91 M(+8.8%) |
| Sep 2023 | - | $6.35 M(-39.3%) |
| Jun 2023 | - | $10.45 M(+75.0%) |
| Mar 2023 | - | $5.97 M(-25.2%) |
| Dec 2022 | $34.77 M(-12.7%) | $7.99 M(-15.9%) |
| Sep 2022 | - | $9.50 M(+12.9%) |
| Jun 2022 | - | $8.41 M(-5.1%) |
| Mar 2022 | - | $8.87 M(-2.7%) |
| Dec 2021 | $39.84 M(-70.1%) | $9.12 M(-16.3%) |
| Sep 2021 | - | $10.90 M(+10.8%) |
| Jun 2021 | - | $9.84 M(-1.5%) |
| Mar 2021 | - | $9.99 M(-61.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $133.08 M(+74.5%) | $25.74 M(-2.5%) |
| Sep 2020 | - | $26.39 M(-33.3%) |
| Jun 2020 | - | $39.58 M(-4.3%) |
| Mar 2020 | - | $41.37 M(+88.6%) |
| Dec 2019 | $76.24 M(+17.0%) | $21.93 M(+25.8%) |
| Sep 2019 | - | $17.43 M(+1.2%) |
| Jun 2019 | - | $17.22 M(-12.5%) |
| Mar 2019 | - | $19.67 M(+6.7%) |
| Dec 2018 | $65.17 M(+90.7%) | $18.44 M(+34.6%) |
| Sep 2018 | - | $13.70 M(-29.1%) |
| Jun 2018 | - | $19.32 M(+40.8%) |
| Mar 2018 | - | $13.72 M(+12.0%) |
| Dec 2017 | $34.17 M(+127.7%) | $12.25 M(+32.5%) |
| Sep 2017 | - | $9.24 M(+38.5%) |
| Jun 2017 | - | $6.67 M(+11.2%) |
| Mar 2017 | - | $6.00 M(+11.7%) |
| Dec 2016 | $15.01 M(+225.7%) | $5.38 M |
| Dec 2015 | $4.61 M | - |
FAQ
- What is VYNE Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for VYNE Therapeutics?
- What is VYNE Therapeutics annual operating expenses year-on-year change?
- What is VYNE Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly operating expenses year-on-year change?
What is VYNE Therapeutics annual total operating expenses?
The current annual operating expenses of VYNE is $44.14 M
What is the all time high annual operating expenses for VYNE Therapeutics?
VYNE Therapeutics all-time high annual total operating expenses is $133.08 M
What is VYNE Therapeutics annual operating expenses year-on-year change?
Over the past year, VYNE annual total operating expenses has changed by +$14.46 M (+48.70%)
What is VYNE Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of VYNE is $12.85 M
What is the all time high quarterly operating expenses for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly total operating expenses is $41.37 M
What is VYNE Therapeutics quarterly operating expenses year-on-year change?
Over the past year, VYNE quarterly total operating expenses has changed by $0.00 (0.00%)